Sophie T Gohy1,2,3, Maha Z Ladjemi4, Charles Pilette5,2,6. 1. Institute of Experimental and Clinical Research - Pole of Pneumology, ENT and Dermatology, Université catholique de Louvain (UCL), Brussels, Belgium. 2. Dept of Pneumology, Cliniques universitaires St-Luc, Brussels, Belgium. 3. Cystic fibrosis reference center, Cliniques universitaires St-Luc, Brussels, Belgium. 4. UMR Inserm U1152, Labex Inflammex, Université Paris 7, Paris Diderot, Paris, France. 5. Institute of Experimental and Clinical Research - Pole of Pneumology, ENT and Dermatology, Université catholique de Louvain (UCL), Brussels, Belgium charles.pilette@uclouvain.be. 6. Institute for Walloon Excellence in Lifesciences and Biotechnology (WELBIO), Brussels, Belgium.
Authors: Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli Journal: Int J Mol Sci Date: 2020-05-08 Impact factor: 5.923